Atrial-selective antiarrhythmic activity by vernakalant fact or fiction?

J Cardiovasc Pharmacol. 2014 Jan;63(1):23-4. doi: 10.1097/FJC.0000000000000024.
No abstract available

Publication types

  • Comment

MeSH terms

  • Animals
  • Anisoles / pharmacology*
  • Anti-Arrhythmia Agents / pharmacology*
  • Cardiac Resynchronization Therapy*
  • Electrophysiological Phenomena / drug effects*
  • Female
  • Flecainide / pharmacology*
  • Hemodynamics / drug effects*
  • Male
  • Pyrrolidines / pharmacology*

Substances

  • Anisoles
  • Anti-Arrhythmia Agents
  • Pyrrolidines
  • vernakalant
  • Flecainide